NTEC Stock Price, News & Analysis

NTEC NASDAQ

Company Description

NTEC (NASDAQ: NTEC) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.

NTEC stock has gained 2227.2% over the past year.

This page provides a comprehensive overview of NTEC stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

+2227.21%

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

NTEC (NTEC) stock. Over the past 12 months, the stock has gained 2227.2%.

Latest News

View All

August 3, 2021

—

Intec Closes Merger with Decoy Biosystems

acquisition

August 3, 2021

-12.48%

Intec Announces Expected Closing Date of Decoy Merger

acquisition

July 26, 2021

-24.63%

Intec Announces $30 Million Private Placement Ahead of Decoy Merger

private placement acquisition

March 17, 2021

-2.47%

Intec Pharma Announces Filing of 2020 Annual Report on Form 10-K

March 15, 2021

+29.85%

Intec Pharma and Decoy Biosystems Announce Merger Agreement

acquisition

December 9, 2020

+34.10%

Intec Pharma Announces Cannabinoid Research Collaboration with GW Pharma

NTEC has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 4 with negative movement. Key topics include acquisition, private placement, earnings, stock split, conferences. View all NTEC news →

SEC Filings

View All

No SEC filings available for NTEC.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

NTEC Company Profile & Sector Positioning

NTEC (NTEC) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.